← Back to All US Stocks

Trulieve Cannabis Corp. (TCNNF) Stock Fundamental Analysis & AI Rating 2026

TCNNF OTC Medicinal Chemicals & Botanical Products A1 CIK: 0001754195
Recently Updated • Analysis: Apr 17, 2026 • SEC Data: 2025-12-31
HOLD
62% Conf
Pending
Analysis scheduled

📊 TCNNF Key Takeaways

Revenue: $1.2B
Net Margin: -9.9%
Free Cash Flow: $228.6M
Current Ratio: 4.43x
Debt/Equity: 0.12x
EPS: $-0.58
AI Rating: HOLD with 62% confidence
Trulieve Cannabis Corp. (TCNNF) receives a HOLD rating with 62% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $1.2B, net profit margin of -9.9%, and return on equity (ROE) of -10.2%, Trulieve Cannabis Corp. demonstrates mixed fundamentals in the Materials sector. Below is our complete TCNNF stock analysis for 2026.

Is Trulieve Cannabis Corp. (TCNNF) a Good Investment?

Claude

Trulieve demonstrates paradoxical fundamentals: strong free cash flow generation ($228.6M, 19.4% FCF margin) and a fortress balance sheet with excellent liquidity (4.43x current ratio) and minimal leverage (0.12x Debt/Equity), but this is severely undermined by persistent net losses (-$116.4M, -9.9% margin), stagnant revenue (-0.4% YoY), and negative shareholder returns (ROE -10.2%, ROA -4.3%). The significant disconnect between positive operating cash flow and negative net income suggests material non-cash charges, acquisitions-related amortization, or accounting adjustments masking core profitability challenges.

Why Buy Trulieve Cannabis Corp. Stock? TCNNF Key Strengths

Claude
  • + Exceptional free cash flow generation of $228.6M with 19.4% FCF margin, demonstrating operational cash generation capability
  • + Fortress balance sheet with excellent liquidity metrics (4.43x current ratio, 2.52x quick ratio) and conservative leverage (0.12x Debt/Equity, 9.8x interest coverage)
  • + Healthy gross margins of 60.2% indicating pricing power and operational efficiency in core cannabis retail operations

TCNNF Stock Risks: Trulieve Cannabis Corp. Investment Risks

Claude
  • ! Persistent net unprofitability (-$116.4M loss) with negative equity returns (ROE -10.2%, ROA -4.3%) destroying shareholder value despite positive cash flow
  • ! Stagnant revenue growth at -0.4% YoY with no evidence of organic expansion in maturing cannabis retail market
  • ! Material divergence between operating cash flow and net income suggests significant non-cash charges, write-downs, or acquisition-related amortization obscuring true profitability
  • ! Cannabis industry regulatory uncertainty with federal legal constraints and state-level variability creating structural business risks

Key Metrics to Watch

Claude
  • * Revenue growth trajectory and comparable store sales trends
  • * Path to net profitability and operating margin sustainability
  • * Operating cash flow-to-net income conversion ratio and identification of non-cash charges
  • * Regulatory developments affecting cannabis scheduling and state licensing

Trulieve Cannabis Corp. (TCNNF) Financial Metrics & Key Ratios

Revenue
$1.2B
Net Income
$-116.4M
EPS (Diluted)
$-0.58
Free Cash Flow
$228.6M
Total Assets
$2.7B
Cash Position
$255.5M

💡 AI Analyst Insight

Strong liquidity with a 4.43x current ratio provides a solid financial cushion.

TCNNF Profit Margin, ROE & Profitability Analysis

Gross Margin 60.2%
Operating Margin 12.1%
Net Margin -9.9%
ROE -10.2%
ROA -4.3%
FCF Margin 19.4%

TCNNF vs Materials Sector: How Trulieve Cannabis Corp. Compares

How Trulieve Cannabis Corp. compares to Materials sector averages

Net Margin
TCNNF -9.9%
vs
Sector Avg 10.0%
TCNNF Sector
ROE
TCNNF -10.2%
vs
Sector Avg 14.0%
TCNNF Sector
Current Ratio
TCNNF 4.4x
vs
Sector Avg 1.6x
TCNNF Sector
Debt/Equity
TCNNF 0.1x
vs
Sector Avg 0.6x
TCNNF Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Trulieve Cannabis Corp. Stock Overvalued? TCNNF Valuation Analysis 2026

Based on fundamental analysis, Trulieve Cannabis Corp. has mixed fundamental signals relative to the Materials sector in 2026.

Return on Equity
-10.2%
Sector avg: 14%
Net Profit Margin
-9.9%
Sector avg: 10%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.12x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Trulieve Cannabis Corp. Balance Sheet: TCNNF Debt, Cash & Liquidity

Current Ratio
4.43x
Quick Ratio
2.52x
Debt/Equity
0.12x
Debt/Assets
57.6%
Interest Coverage
9.78x
Long-term Debt
$136.7M

TCNNF Revenue & Earnings Growth: 5-Year Financial Trend

TCNNF 5-year financial data: Year 2021: Revenue $938.4M, Net Income $53.1M, EPS $0.46. Year 2022: Revenue $1.2B, Net Income $63.0M, EPS $0.53. Year 2023: Revenue $1.2B, Net Income N/A, EPS $0.21. Year 2024: Revenue $1.2B, Net Income N/A, EPS $-0.95. Year 2025: Revenue $1.2B, Net Income N/A, EPS $-2.28.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Trulieve Cannabis Corp.'s revenue has grown significantly by 26% over the 5-year period, indicating strong business expansion. The most recent EPS of $-2.28 indicates the company is currently unprofitable.

TCNNF Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
19.4%
Free cash flow / Revenue

TCNNF Quarterly Earnings & Performance

Quarterly financial performance data for Trulieve Cannabis Corp. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $284.3M N/A N/A
Q2 2025 $302.1M N/A N/A
Q1 2025 $297.6M N/A $-0.16
Q3 2024 $275.2M -$25.8M $-0.12
Q2 2024 $281.8M -$12.0M $-0.04
Q1 2024 $285.2M -$24.5M $-0.16
Q3 2023 $275.2M -$24.0M $-0.12
Q2 2023 $281.8M -$24.0M $-0.09

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Trulieve Cannabis Corp. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
$272.8M
Cash generated from operations
Capital Expenditures
$44.2M
Investment in assets
Dividends
None
No dividend program

TCNNF SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Trulieve Cannabis Corp. (CIK: 0001754195)

📋 Recent SEC Filings

Date Form Document Action
Mar 17, 2026 4 xslF345X05/primary_doc.xml View →
Mar 17, 2026 4 xslF345X05/primary_doc.xml View →
Mar 17, 2026 4 xslF345X05/primary_doc.xml View →
Mar 17, 2026 4 xslF345X05/primary_doc.xml View →
Mar 17, 2026 4 xslF345X05/primary_doc.xml View →

Frequently Asked Questions about TCNNF

What is the AI rating for TCNNF?

Trulieve Cannabis Corp. (TCNNF) has an AI rating of HOLD with 62% confidence, based on fundamental analysis of SEC EDGAR filings.

What are TCNNF's key strengths?

Claude: Exceptional free cash flow generation of $228.6M with 19.4% FCF margin, demonstrating operational cash generation capability. Fortress balance sheet with excellent liquidity metrics (4.43x current ratio, 2.52x quick ratio) and conservative leverage (0.12x Debt/Equity, 9.8x interest coverage).

What are the risks of investing in TCNNF?

Claude: Persistent net unprofitability (-$116.4M loss) with negative equity returns (ROE -10.2%, ROA -4.3%) destroying shareholder value despite positive cash flow. Stagnant revenue growth at -0.4% YoY with no evidence of organic expansion in maturing cannabis retail market.

What is TCNNF's revenue and growth?

Trulieve Cannabis Corp. reported revenue of $1.2B.

Does TCNNF pay dividends?

Trulieve Cannabis Corp. does not currently pay dividends.

Where can I find TCNNF SEC filings?

Official SEC filings for Trulieve Cannabis Corp. (CIK: 0001754195) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is TCNNF's EPS?

Trulieve Cannabis Corp. has a diluted EPS of $-0.58.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is TCNNF a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Trulieve Cannabis Corp. has a HOLD rating with 62% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is TCNNF stock overvalued or undervalued?

Valuation metrics for TCNNF: ROE of -10.2% (sector avg: 14%), net margin of -9.9% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.

Should I buy TCNNF stock in 2026?

Our dual AI analysis gives Trulieve Cannabis Corp. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is TCNNF's free cash flow?

Trulieve Cannabis Corp.'s operating cash flow is $272.8M, with capital expenditures of $44.2M. FCF margin is 19.4%.

How does TCNNF compare to other Materials stocks?

Vs Materials sector averages: Net margin -9.9% (avg: 10%), ROE -10.2% (avg: 14%), current ratio 4.43 (avg: 1.6).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 17, 2026 | Data as of: 2025-12-31 | Powered by Claude AI